Human I-FABP ELISA Kit | I-FABP elisa kit
I-FABP, Human, ELISA Kit
Reactivity
Human
Synonyms
I-FABP; Human; ELISA Kit; FABP2; FABPI; I-FABP elisa kit
Reactivity
Human
Sequence Length
132
Application Notes
Application Notes: The human I-FABP ELISA Kit is intended for the quantitative measure-ment of human I-FABP in cell culture medium, serum, plasma and urine.
Intended Uses
The human I-FABP ELISA kit is to be used for the in vitro quantitative determination of human I-FABP in serum, plasma, urine and cell culture supernatant samples. This kit is intended for laboratory research use only and is not for use in therapeutic procedures.
Preparation and Storage
Product should be stored at 4 degree C. Under recommended storage conditions, product is stable for one year.
Related Product Information for I-FABP elisa kit
Background: Fatty acid-binding proteins (FABPs) are a class of cytoplasmic proteins that bind long chain fatty acids. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity. They are abundantly present in various cell types and play an important role in the intracellular utilization of fatty acids, transport and metabolism. There are at least nine distinct types of FABP, each showing a specific pattern of tissue expression. Due to its small size, FABP leaks rapidly out of ischemically damaged necrotic cells leading to a rise in serum levels. Ischemically damaged tissues are characterized histologically by absence (or low presence) of FABP facilitating recognition of such areas.
References
1. Niewold, T et al; Plasma intestinal fatty acid binding protein (I-FABP) concentrations increase following intestinal ischemia in pigs. Res Vet Sci 2004, 77: 89
2. Morariu, A et al; Dexamethasone: benefit and prejudice for patients undergoing onpump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005, 128: 2677
3. Derikx, J et al; Detection of chemotherapy-induced enterocyte toxicity with circulating intestinal fatty acid binding protein. J Pediatr Hematol Oncol 2006, 28: 267
4. Cronk, D et al; Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 2006, 63: 322
5. Derikx, P et al; Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 2007, 56: 1473
2. Morariu, A et al; Dexamethasone: benefit and prejudice for patients undergoing onpump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005, 128: 2677
3. Derikx, J et al; Detection of chemotherapy-induced enterocyte toxicity with circulating intestinal fatty acid binding protein. J Pediatr Hematol Oncol 2006, 28: 267
4. Cronk, D et al; Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 2006, 63: 322
5. Derikx, P et al; Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 2007, 56: 1473
NCBI and Uniprot Product Information
NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
NCBI Official Full Name
intestinal fatty acid binding protein
NCBI Official Symbol
I-FABP
NCBI Protein Information
intestinal fatty acid binding protein
Similar Products
Product Notes
The Human I-FABP (Catalog #AAA584526) is an ELISA Kit and is intended for research purposes only. The product is available for immediate purchase. The AAA584526 ELISA Kit recognizes Human I-FABP. Application Notes: The human I-FABP ELISA Kit is intended for the quantitative measure-ment of human I-FABP in cell culture medium, serum, plasma and urine. Researchers should empirically determine the suitability of the I-FABP for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "I-FABP, ELISA Kit" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
